Sort
48,018 grants matching “immunotherapy”
Tuning peptide specifities for T cell tolerance in Type 1 diabetes
$468,463Mark S Anderson · University Of California, San Francisco · R01 · FY2023 · DK
Targeting immune inhibitory molecule SUSD2 to reverse immunosuppression
$468,437Haitao Wen · Ohio State University · R01 · FY2023 · AI
Targeting immune inhibitory molecule SUSD2 to reverse immunosuppression
$468,437Haitao Wen · Ohio State University · R01 · FY2025 · AI
Targeting immune inhibitory molecule SUSD2 to reverse immunosuppression
$468,437Haitao Wen · Ohio State University · R01 · FY2022 · AI
Targeting immune inhibitory molecule SUSD2 to reverse immunosuppression
$468,437Haitao Wen · Ohio State University · R01 · FY2024 · AI
Mechanisms of initiation of T-cell signaling by the TCR-CD3 complex
$468,382Michelle Krogsgaard · New York University School Of Medicine · R01 · FY2021 · GM
Cancer cell-intrinsic mitochondrial stress responses influence protective immunity
$468,373Kyle Kristopher Payne · Rutgers Biomedical And Health Sciences · R37 · FY2025 · CA
The DARC side of Breast Cancer Disparities - African Ancestry and Cancer- Related Immune Response
$468,366Melissa B Davis · Morehouse School Of Medicine · R01 · FY2023 · CA
Function of Wdfy4 in cross-presentation and immunity
$468,344Kenneth M. Murphy · Washington University · R01 · FY2019 · AI
Synthetics PNAG and multi-component vaccines against emerging pathogens
$468,318Gerald B Pier · Harvard Medical School · U54 · FY2012 · AI
TBD
$468,316Shuzhao Li · Jackson Laboratory · R01 · FY2022 · AI
ImmunoMetabolomics of Zoster Vaccines
$468,316Shuzhao Li · Jackson Laboratory · R01 · FY2024 · AI
TBD
$468,316Shuzhao Li · Jackson Laboratory · R01 · FY2023 · AI
Targeting UHRF1 in combinational immunotherapy
$468,277Xiao-Fan Wang · Duke University · R01 · FY2021 · CA
Adoptive Transfer of Donor Tregs Specific Against Host Alloantigens for Presentio
$468,268Claudio Anasetti · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2013 · HL
Targeting the innate immune response in HNSCC
$468,267Judith A. Varner · University Of California, San Diego · R01 · FY2021 · DE
Targeting the innate immune response in HNSCC
$468,267Judith A. Varner · University Of California, San Diego · R01 · FY2018 · DE
Targeting the innate immune response in HNSCC
$468,267Judith A. Varner · University Of California, San Diego · R01 · FY2020 · DE
Mechanisms of cell death in cutaneous melanoma
$468,265Andrew E Aplin · Thomas Jefferson University · R01 · FY2023 · CA
Project 3 - Zuniga
$468,247Elina I Zuniga · University Of California, San Diego · P01 · FY2018 · AI
Promoting immunity against acute myeloid leukemia through Fc effector-optimized antibody inhibitory of MICA/B shedding
$468,199Lucas Ferrari De Andrade · Icahn School Of Medicine At Mount Sinai · R37 · FY2024 · CA
An innate immune checkpoint in cancer immunotherapy
$468,186Carla Rothlin · Yale University · R01 · FY2018 · CA
High-Specificity Imaging Agents for Aggressive Prostate Cancer
$468,164Martin G Pomper · Johns Hopkins University · R01 · FY2017 · CA
Targeting UHRF1 in combinational immunotherapy
$468,148Xiao-Fan Wang · Duke University · R01 · FY2020 · CA
Investigating the Immunosuppressive Function of lncRNA CRNDE in Hepatic Tumorigenesis
$468,139Jinqiang Zhang · Tulane University Of Louisiana · R01 · FY2025 · CA